10-116849716-C-A
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_001242699.2(ENO4):c.150C>A(p.Asp50Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000106 in 1,529,216 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001242699.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000788 AC: 12AN: 152208Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000628 AC: 8AN: 127486Hom.: 0 AF XY: 0.0000441 AC XY: 3AN XY: 68036
GnomAD4 exome AF: 0.000109 AC: 150AN: 1377008Hom.: 0 Cov.: 30 AF XY: 0.0000960 AC XY: 65AN XY: 676920
GnomAD4 genome AF: 0.0000788 AC: 12AN: 152208Hom.: 0 Cov.: 32 AF XY: 0.0000807 AC XY: 6AN XY: 74346
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.150C>A (p.D50E) alteration is located in exon 1 (coding exon 1) of the ENO4 gene. This alteration results from a C to A substitution at nucleotide position 150, causing the aspartic acid (D) at amino acid position 50 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at